Medical News

RSS

Additional Zenvia Phase III results in multiple sclerosis announced by AVANIR

AVANIR Pharmaceuticals, Inc. (NASDAQ:AVNR) today announced additional detailed results from the confirmatory double-blind Phase III STAR trial evaluating two doses of the investigational drug Zenvia™ (dextromethorphan/quinidine) compared to placebo in the treatment of pseudobulbar affect (PBA) among patients with underlying multiple sclerosis (MS) or amyotrophic lateral sclerosis (ALS). Over the course of the 12-week study in the MS patient subset, Zenvia 30/10 mg met the primary efficacy endpoint by reducing PBA episode rates by an incremental 11.9% beyond placebo

9 Oct 2009

Cantel Medical announces fiscal 2009 fourth-quarter and full-year financial results

CANTEL MEDICAL CORP. reported a 65% increase in net income to $4,279,000, or $0.26 per diluted share, on a 4% increase in sales to a record $66,793,000 for the fourth quarter ended July 31, 2009. This compares with net income of $2,596,000, or $0.16 per diluted share, on sales of $64,281,000 for the fourth quarter ended July 31, 2008.

9 Oct 2009

MedaSorb Technologies raises $1.3 million to help finance ongoing European Sepsis Trial

MedaSorb Technologies Corporation and its wholly-owned subsidiary CytoSorbents, Inc., announced that it has raised $1.3 million in the exercise of the warrant attached to the Series B financing completed in August 2008. Dr. Phillip Chan, Chief Executive Officer, stated, "We are pleased to have the continued support of our existing investors.

9 Oct 2009

Aspen Institute and TIME magazine to present panel discussions on health care reform

With health care reform headed to the floor of the House and Senate, the Aspen Institute and TIME magazine will present a day of panel discussions designed to shed light on what the looming changes will mean for the American people.

9 Oct 2009

Mediacorp Canada selects MDS Nordion as one of Canada's Top 100 Employers for 2010

MDS Nordion, a leading provider of medical isotopes and radiopharmaceuticals, has been selected as one of Canada's Top 100 Employers for 2010 by Mediacorp Canada, the nation's largest publisher of employment-related periodicals and online directories.

9 Oct 2009

Verichip Corporation's H1N1 virus triage detection system to feature in Fox News

VeriChip Corporation has announced that the Company is scheduled to be featured on the Glenn Beck show on Fox News today, October 8, 2009 during the 5 p.m. hour. Glenn Beck intends to dedicate today's show to the H1N1 virus and will feature VeriChip, its Health Link personal health record and its H1N1 virus triage detection system currently being developed with partner RECEPTORS LLC, as part of the show.

9 Oct 2009

LeVOCC air purification system destroys the PR8 strain of the H1N1 virus

LeVOCC, Inc. today announced that independent laboratory testing has conclusively demonstrated that the LeVOCCTM air purification system successfully destroys a strain of the H1N1 virus. Testing was conducted using the Puerto Rico 8 (PR8) strain of the H1N1 virus. This strain is an influenza A H1N1 seasonal strain and is a valid representative of all H1N1 strains.

9 Oct 2009

Manual microdissection to remove biopsy cavities from breast cancer specimens essential

Genomic Health, Inc. today announced results from a study demonstrating the critical role of manual microdissection to remove all biopsy cavities from breast cancer specimens. Genomic Health's Oncotype DX is the only commercially available breast cancer test that employs manual microdissection following review by a board certified surgical pathologist with breast expertise to predict a patient's benefit from chemotherapy and risk of disease recurrence.

9 Oct 2009

Smart For Life launches its weight loss program on BJ's Wholesale Club's e-commerce website

Smart For Life(TM) Cookie Diet, the all-natural weight management program, announces its launch today as the only weight loss program on BJ's Wholesale Club's e-commerce website (http://www.bjs.com). Reaching out to a wider audience, Smart For Life(TM) partnered with BJ's to provide convenience and value to BJ's members searching for weight loss and healthy, lifestyle foods.

9 Oct 2009

Czura Thornton to buy MDS' Central Labs operation

MDS Inc., a leading provider of products and services to the global life sciences markets, today announced that it has signed an agreement to sell its Central Labs operation, which conducts analysis of samples from late-stage clinical trials to Czura Thornton, a private investment group based in Jersey, Channel Islands.

From Danaher 9 Oct 2009

IMIA accredits workshops to provide Continuing Education Units for medical interpreters

The International Medical Interpreters Association (IMIA) announced its capability to accredit workshops to provide Continuing Education Units (CEUs) for medical interpreters, in all languages worldwide. The organization sets this as a concrete step to professionalize medical interpreters.

9 Oct 2009

OncoGenex Pharmaceuticals president named Canada's Pacific Ernst & Young's Entrepreneur Of The Year

OncoGenex Pharmaceuticals, Inc., announced today that Scott Cormack, president and chief executive officer of OncoGenex, has been named Canada's Pacific Ernst & Young's Entrepreneur Of The Year(R). The Ernst & Young Entrepreneur Of The Year(R) Award is a high profile business award recognizing entrepreneurs that are building successful, dynamic businesses.

9 Oct 2009

Hepatitis A to be included in Expanded Programme on Immunization in 2010

HTDS www.htdsmedical.com (HTDS) - The issuer's China based operating subsidiary Mellow Hope www.mellowhope.com is pleased to announce the clinical protocol is in the process of being approved. It is known that the Hepatitis A will be included in the Expanded Programme on Immunization (EPI) in 2010.

9 Oct 2009

Courtyard Group commends Auditor General's report on eHealth initiative

Courtyard Group today responded after reviewing details of the Ontario Auditor General's report on the eHealth initiative.

9 Oct 2009

Government of Quebec develops new strategy to strengthen biopharmaceutical sectors

In the midst of challenging economic times, the announcement of the Quebec government's biopharmaceutical strategy is good news for basic pharmaceutical research and patient access to innovative medicines, said Dawn Graham, President of Merck Frosst Canada today in response to the release of the Quebec Pharmaceutical Strategy.

9 Oct 2009

Medicago receives contract from U.S. Army Research, Development and Engineering Command laboratory

Medicago Inc. (TSX-V: MDG), a biotechnology company focused on developing highly effective and affordable vaccines based on proprietary manufacturing technologies and Virus-Like Particles (VLPs), today announced that it has been awarded a proof of concept contract by the U.S. Army Research, Development and Engineering Command laboratory specifically the Edgewood Chemical Biological Center ("ECBC") Research & Technology Directorate.

9 Oct 2009

Ministry of Health protects for-profit health care corporations while closing non-profit medical laboratories

Documents released after a two year Freedom of Information battle reveal almost complete control of Ontario's community medical laboratory services by three multinational corporations.

9 Oct 2009

AST assembles at Capitol Hill to support health care reform for kidney transplant recipients

As Congress wraps up work on health care reform, members of the American Society of Transplantation's (AST) Public Policy Committee arrived on Capitol Hill today to discuss the importance of supporting a health care provision that would ensure kidney transplant recipients continue to receive.

9 Oct 2009

New study: Economic crisis a major barrier to U.S. life settlements market

The life settlements market was hit hard by the economic crisis and other factors in 2008, according to a new study by Conning Research and Consulting.

9 Oct 2009

20 million school-age children across 26 countries to be dewormed in 2009

Deworm the World (DtW) and their Clinton Global Initiative (CGI) education mega-commitment partners will deworm 20 million school-age children across 26 countries in 2009, doubling the original commitment target for year one of 10 million children in 19 countries.

9 Oct 2009

Medical News

Additional Zenvia Phase III results in multiple sclerosis announced by AVANIR

Cantel Medical announces fiscal 2009 fourth-quarter and full-year financial results

MedaSorb Technologies raises $1.3 million to help finance ongoing European Sepsis Trial

Aspen Institute and TIME magazine to present panel discussions on health care reform

Mediacorp Canada selects MDS Nordion as one of Canada's Top 100 Employers for 2010

Verichip Corporation's H1N1 virus triage detection system to feature in Fox News

LeVOCC air purification system destroys the PR8 strain of the H1N1 virus

Manual microdissection to remove biopsy cavities from breast cancer specimens essential

Smart For Life launches its weight loss program on BJ's Wholesale Club's e-commerce website

Czura Thornton to buy MDS' Central Labs operation

IMIA accredits workshops to provide Continuing Education Units for medical interpreters

OncoGenex Pharmaceuticals president named Canada's Pacific Ernst & Young's Entrepreneur Of The Year

Hepatitis A to be included in Expanded Programme on Immunization in 2010

Courtyard Group commends Auditor General's report on eHealth initiative

Government of Quebec develops new strategy to strengthen biopharmaceutical sectors

Medicago receives contract from U.S. Army Research, Development and Engineering Command laboratory

Ministry of Health protects for-profit health care corporations while closing non-profit medical laboratories

AST assembles at Capitol Hill to support health care reform for kidney transplant recipients

New study: Economic crisis a major barrier to U.S. life settlements market

20 million school-age children across 26 countries to be dewormed in 2009

Evolving spectrophotometry for modern biopharma workflows

Scaling B-cell cloning workflows for antibody development

Fluidics in Modern Healthcare & Medical Device Innovation

Latest News